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The Christchurch Health and Development Study is a longitudinal study of a birth cohort of 1265 
children who were born in Christchurch New Zealand in 1977. This cohort has now been studied 
from birth to the age of 35. This article examines a series of findings from the CHDS that address a 
range of issues relating to the use of cannabis amongst the cohort. These issues include: 
 Patterns of cannabis use and cannabis dependence 
 Linkages between cannabis use and adverse educational and economic outcomes 
 Cannabis and other illicit drug use 
 Cannabis and psychotic symptoms 
 Other CHDS findings related to cannabis 
 The consequences of cannabis use for adults using cannabis regularly 
In general, the findings of the CHDS suggest that individuals who use cannabis regularly, or who 
begin using cannabis at earlier ages, are at increased risk of a range of adverse outcomes, including: 
lower levels of educational attainment; welfare dependence and unemployment; using other, more 
dangerous illicit drugs; and psychotic symptomatology.  It should also be noted, however, that there 
is a substantial proportion of regular adult users who do not experience harmful consequences as a 
result of cannabis use.  Collectively, these findings suggest that cannabis policy needs to be further 
developed and evaluated in order to find the best way to regulate a widely-used, and increasingly 
legal substance.  
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Over the last two decades there have been ongoing debates about the extent to which the use of 
cannabis/marijuana has harmful effects upon users [1-4]. These debates have tended to polarise 
into two groups; first, those who tend of minimise the potential harmful effects of cannabis and 
argue strongly for the liberalisation of cannabis laws and permitting access to legal cannabis [5-7]; 
and second, those who view cannabis as a harmful drug for which continued prohibition is the 
correct approach [8,9]. 
 
One of the inevitable features of research into the harmful effects of cannabis is that research has 
been conducted in different settings, using different research designs and measurement methods. 
While this heterogeneity has benefits for examining the generality of findings about cannabis, it also 
has some limitations, as the results from different studies may make it difficult to provide a clear 
picture of the ways in which cannabis use may influence the health and wellbeing of a particular 
population. 
 
Against this background the aims of this paper are to provide an overview of the findings of a large 
longitudinal study in which the use of cannabis has been studied from mid-adolescence (age 14) to 
mature adulthood (age 35). This study is the Christchurch Heath and Development Study, which is a 
longitudinal study of a birth 1265 cohort of children born in the Christchurch (New Zealand) area in 
mid-1977.  The cohort consisted of 97% of all live births in the greater Christchurch region during 
this period, and as such is a representative population.  This cohort has been studied on 23 occasions 
from birth to age 35, with extensive data on issues of health and wellbeing being gathered.   Sample 
retention in the study has been good and at age 35, a sample of 962 respondents was studied, with 
this sample representing 79% of the cohort. 
 
Over the years the CHDS has published 30 articles on the use, misuse and consequences of cannabis 
over the period from adolescence. In this paper we provide a summary overview and synthesis of 
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the study findings on the potentially harmful effects of cannabis. We also supplement these findings 
to describe those adult cannabis users who use the drug regularly and in a non-problematic way.  
What we seek to show in this review is that: 
a) Cannabis is a drug that has harmful effects in the areas of educational achievement,  
personal adjustment, mental health and related outcomes; 
b) Despite this, there is a substantial minority of cannabis users who do not experience adverse 
consequences of the drug. 
These issues highlight the importance of developing laws and policies relating to cannabis that 
consider the risks of cannabis, whilst at the same time recognising the rights of those who use the 
drug in a non-problematic way. 
 
Patterns of cannabis use and cannabis dependence in the CHDS cohort 
Figure 1 (Panels a and b) summarises the history of cannabis use and cannabis dependence in the 
CHDS cohort from ages 14 to 35 years. Figure 1 Panel a shows annual rates of cannabis use and 
cannabis dependence at ages 15, 18, 21, 25, 30, and 35 years. The following measures of use are 
reported: any use; regular (at least weekly) use; and dependent use. The measure of dependent use 
was based on DSM-III-R (at age 15) and DSM-IV (ages 18-35) criteria for cannabis dependence. The 
Figure suggests substantial usage by the cohort with: a) annual rates of use ranging from 8.7 to 
46.8%; b) annual rates of regular use ranging from 0.7 to 15.6%, and; c) annual rates of dependence 
ranging from 0% to 6.9%. These data clearly show a general tendency for the rates of cannabis use 
to be highest during the mid-twenties.  At all ages, however, the largest group of cannabis users 
were occasional (less than monthly) users of the drug. 
 
Figure 1 Panel b shows estimates of the probability that cohort members would: a) use cannabis; b) 
use cannabis regularly (at least weekly); and c) become cannabis dependent, by each assessment at 
ages 15 to 35 years.  All estimates suggest a high rate of cannabis use in the cohort, with 
approximately 80% of cohort members using cannabis on at least one occasion, 33.6% of the cohort 
5 
 
being regular users during at some point by age 35, and 15.2% of the cohort meeting criteria for 
cannabis dependence.  The generally high use of cannabis use in the CHDS cohort and the wide 
variability in use makes it an ideal sample with which to examine the consequences of cannabis use 
for development and wellbeing. 
INSERT FIGURE 1 HERE 
 
Cannabis use and educational achievement, welfare dependence, and unemployment 
One area of increasing research interest is the extent to which the use of cannabis, and in particular 
earlier and heavier use of cannabis, may have adverse effects on educational achievement [10-13], 
and related outcomes such as welfare dependence [14-16] and unemployment [17-19].  The 
longitudinal data collected as part of the CHDS have provided the opportunity to examine these 
issues.  The results of a recent analysis of CHDS data [20] is presented in Figure 2 Panel a, which 
shows the associations between the age of onset of cannabis use and educational outcomes, after 
adjustment for a wide range of confounding factors, including: parental education; family 
socioeconomic status at birth; childhood family living standards; scholastic ability (as measured at 
age 13); teacher-rated grade point average (ages 11-13); and childhood conduct problems.  The 
Figure shows that for all outcomes, the age of onset of cannabis use was related to lower levels of 
educational attainment.  As a general rule, those using cannabis prior to age 15 had the poorest 
outcomes, while those who did not use cannabis prior to age 18 had the best outcomes.   
 
Further analyses of CHDS data [21] examined the linkages between cannabis use during the period 
15-21 years and: a) the receipt of welfare benefits; and b) a period of unemployment; during the 
period 21-25 years.  In these analyses, cannabis use was classified using a six-level variable 
representing an estimate the self-reported total number of times an individual had used cannabis 
during the period 15-21 years.  The findings of these analyses are shown in Figure 2 (Panels b and c), 
which depict the odds ratios for welfare dependence and unemployment, for varying levels of 
cannabis consumption (relative to non-users), after adjustment for confounding factors (including 
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measures of: the socio-economic background of the family of origin; family functioning and exposure 
to adversity; exposure to child sexual and physical abuse; childhood and adolescent adjustment; 
academic achievement in early adolescence; and comorbid mental health disorders and substance 
use).  The Figure clearly depicts a dose-response association in which the increasing use of cannabis 
during the period 15-21 years increases the risk of both welfare dependence and unemployment 
during the period 21-25 years.  Those who reported using cannabis on 400 or more occasions had 
odds of welfare dependence that were almost five times greater than those who did not use 
cannabis, and odds of unemployment which were more than three times greater than those who did 
not use cannabis.   
 
INSERT FIGURE 2 HERE 
 
The linkages between cannabis use and educational and economic outcomes have several possible 
explanations.  The first explanation is that the use of cannabis may have consequences for 
neurophysiological structure and functioning, compromising motivation and cognitive processes 
[12,22,23].  Although speculative at the present time, this explanation does have a growing evidence 
base related to the neurochemistry of cannabis and the vulnerability of the developing adolescent 
brain [24,25].   
 
A second explanation of the linkages between cannabis use and lower levels of educational 
achievement is that the use of cannabis may introduce young people to social contexts in which anti-
conventional behaviour is encouraged, and more normative behaviours related to educational 
achievement are seen as less attractive [26-28].  It seems likely that the associations between 
cannabis use and educational attainment and related outcomes reflect the cumulative effects of 
both biological and social factors that increase the vulnerability of cannabis users to educational 




Cannabis use and other illicit drug use – the cannabis gateway hypothesis 
Another area of long-standing interest in research on the consequences of cannabis use is the 
possible link between the use of cannabis and an increased risk of using other illicit drugs.  Known as 
the “stepping stone” or “gateway” hypothesis, this theory suggests that exposure to cannabis 
increases the likelihood that an individual will use illicit drugs other than cannabis at some later 
point [29-35].  A key implication arising from this hypothesis is that while cannabis itself may be a 
drug with relatively low harm levels, the linkages between cannabis and more harmful drugs such as 
cocaine or heroin indirectly increases the harm caused by cannabis consumption.   
 
A critical issue in evaluating the gateway hypothesis concerns the extent to which the associations 
between cannabis use and other illicit drug use can be explained by third or confounding factors.  It 
has been argued, for example, that the association may arise because of common factors that 
predispose young people to use both cannabis and other illicit drugs [36-38], and that controlling for 
these factors may account for the linkages between cannabis use and other illicit drug use.   
However, other studies employing often extensive control for confounding factors reported that 
associations between cannabis use and other illicit drug use could not be explained by confounding 
factors [27,39,40]. 
 
A potential criticism of much of this research is that studies had only controlled observed covariates, 
and that any remaining association between cannabis use and other illicit drug use could be 
attributed to residual confounding [41].  This raises important issues about methods for controlling 
both observed and non-observed confounding.  Conventionally, issues of confounding have been 
addressed in epidemiological research by adjusting associations between outcomes and potentially 
causative factors for observed confounders such as age, race, and social, family and childhood 
background. The difficulty with such analyses is that it is always possible to suggest the presence of 
non-observed confounders which explain the observed association.  The conditional fixed effects 
regression model provides an important technique for addressing the issue of omitted confounders. 
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The general logic of this approach can be illustrated by a study in which the same sample is assessed 
on two occasions (t1; t2) with assessments of illicit drug use (Yt) and a time varying predictor X being 
collected. We assume that the associations between Yt and Xt are described by the model: 
                                
Y1=  B X1 + U +E1    (EQ1) 
                             Y2 = B X2 + U +E2    (EQ2) 
where U denotes non-observed factors that have fixed and enduring consequences on the measures 
of illicit drug use, Y1 and Y2, and Et is a random error term that is uncorrelated with X and 
uncorrelated between time periods.  The fixed effects factor U is permitted to be correlated 
with  X1, X2 and thus potentially confounds the relations between Yt and Xt.   The effects of the non-
observed fixed factor U can be taken into account by subtracting EQ2 from EQ1: 
            (Y1- Y2) = B1(X1-X2) + (E1 – E2)   (EQ3) 
It will be evident that the model in EQ3 provides an estimate of the parameter of interest B1 in a 
way that excludes the influence of the fixed effects factor U.   
The principles illustrated above can be generalised to develop fixed effect adjusted estimates for a 
wide range of statistical models [42,43]. In addition the models may be extended to include 
observed time-dynamic covariate factors that may also account for the associations between 
exposure and outcome.  Indeed, all analyses of CHDS data employed fixed effects regression models 
have also included a range of time-dynamic covariate factors to address the potential issue of 
omitted variables. 
The fixed effects model can be used for any situation in which there is interest in the causal effects 
of a time-dynamic predictor and time-dynamic measures of outcome. This approach has been used 
in a number CHDS publications [44-49,30,50-52]. One specific application of this approach is to 
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examine the associations between cannabis use and other illicit drug use, taking into account non-
observed sources of confounding. 
Data from the CHDS have been used in two papers examining the linkages between cannabis use 
and other illicit drug use [30,40].    By age 25, three-quarters of the remaining cohort had reported 
using cannabis on at least one occasion, and approximately 40% had reported using illicit drugs 
other than cannabis at least once.  Of the cohort members who had used both cannabis and other 
illicit drugs, all but a single individual reported using cannabis at an earlier point in time than using 
other illicit drugs.  These drugs included: cocaine; heroin or other opiates; hallucinogens such as LSD 
or psilocybin mushrooms; party drugs including MDMA; stimulants including amphetamine; 
sedatives; solvents; prescription medications taken for recreational purposes; or other substances 
including nitrous oxide. 
 
Figure 3 Panel a shows the unadjusted associations between frequency of cannabis use at different 
ages (14-15 years; 17-18 years; 20-21 years; and 24-25 years) and rates of use of other illicit drugs.  
The Figure Panel a clearly shows a dose-response relationship such that increasing frequency of 
cannabis use at each age is linked to increasing rates of other illicit drugs.   
 
In order to control for non-observed sources of confounding, CHDS data were used to fit conditional 
fixed effects regression models to the data for cannabis use and other illicit drug use over the period 
14-25 years [30].  These models were augmented with a series of time-dynamic covariate factors 
observed during the period 14-25 years, which included measures of: mental health disorders; 
alcohol use disorders; nicotine dependence; life stress; unemployment; deviant peer affiliations; 
partner deviant behaviour; and several other lifestyle-related factors.  Estimates of the adjusted 
associations between varying levels of cannabis use and other illicit drug use derived from the fitted 
models are presented in Figure 3 Panel b, which shows estimates of the adjusted OR for other illicit 
drug use pooled over the period 14-25 years.  The Figure Panel b shows that after adjustment there 
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remained a strong and statistically significant association between cannabis use and other illicit drug 
use.    
 
INSERT FIGURE 3 HERE 
 
It is also important to note that the fixed effects regression models also contained a term 
representing an age by frequency of cannabis use interaction, which was statistically significant (p < 
.05).  The negative slope parameter of the interaction term indicated that the associations between 
cannabis use and other illicit drug use were stronger at younger ages.  For example, estimates from 
the fitted models indicated that at ages 14-15 those who used cannabis at least weekly had odds of 
other illicit drug use that were approximately 66 times higher than non-users.  By ages 24-25, the 
odds of other illicit drug use amongst weekly cannabis users had declined to 3.9 times higher than 
non-users. 
 
The results of these analyses clearly suggest the presence of a causal association between the use of 
cannabis and the use of other illicit drugs.  Possible causal mechanisms include: 
 Neurobiological effects of cannabis which may encourage illicit drug use [53-55]; 
 The effects of the illegality of cannabis use in increasing the contact of cannabis users with 
the illicit drug market [35,56,57]; 
 The effects of peer support and influence in encouraging the use of cannabis and other illicit 
drugs [58-60]; 
 Social learning processes by which cannabis users learn to experiment with other illicit drugs 
[61,62,60]; 
 
Cannabis use and psychotic symptomatology 
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A further area of research interest in the sequelae of cannabis use has been the linkages between 
cannabis use and psychotic symptoms.  A number of longitudinal studies [63,64,51,65,66] have 
found increased rates of psychosis or psychotic symptoms in those using cannabis.  However, it 
could be argued that these findings may have arisen due to: a) sources of non-observed confounding 
that increased the risk of both cannabis use and psychotic symptoms; of b) reverse causal processes 
in which the experience of psychotic symptoms increased the risk of cannabis use. 
 
In order to examine these issues, data from the CHDS on cannabis use and psychotic 
symptomatology during the period 18-25 years were used to fit conditional fixed effects models of 
cannabis use and symptoms of psychosis, net of non-observed sources of confounding and time-
dynamic covariate factors [51].  The results of these analyses are shown in Figure 4, which depicts 
the incidence rate ratio (IRR) for psychotic symptomatology, for four levels of cannabis use, after 
controlling for both non-observed fixed effects and time-dynamic covariate factors.  The Figure 
clearly shows a dose-response association between cannabis use and psychotic symptomatology, in 
which increasing levels of cannabis use are associated with increased risk of symptoms of psychosis.  
After adjustment for both non-observed fixed effects and time-dynamic covariate factors, those who 
used cannabis on a daily basis had rates of psychotic symptoms that were 1.75 times higher than 
those who did not use cannabis.  These data were consistent with a causal explanation of the role of 
cannabis in increasing the risk of psychotic symptoms. 
 
INSERT FIGURE 4 HERE 
 
Although the analyses above established that there was an association between cannabis use and 
psychotic symptoms net of non-observed sources of confounding and time-dynamic covariate 
factors, the evidence does not establish the direction of causation.  In particular, there are 
potentially two causal pathways that link cannabis use and psychosis.  First, cannabis use may lead 
(via changes in neurophysiological functioning) to increased susceptibility to psychotic symptoms.  
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Alternatively, those developing psychosis may have an increased susceptibility to using cannabis as a 
consequence of their psychological state.   Addressing this issue proves to be difficult and even with 
well-collected longitudinal data, establishing which factor is antecedent and which factor is 
consequent not straightforward [67,68].  Furthermore, there is a possibility that cannabis use and 
psychosis are related to each other reciprocally by a feedback loop in which the use of cannabis 
increases risks of psychosis while at the same time the onset of psychosis leads to an increased 
consumption of cannabis.  Structural equation models provide one means of addressing such a 
complex issue by devising statistical models that permit reciprocal relationships between cannabis 
use and psychosis and using these models to guide probable patterns of causation.  This approach to 
determining likely patterns of causality has been used in a number of CHDS publications 
[51,69,48,70]. 
 
In order to examine these issues, a structural equation model was fitted to the data which: a) 
allowed the estimation of pathways from cannabis to psychosis, and vice-versa; b) accounted for 
auto-regressive effects for cannabis and psychosis over time; and c) accounted for non-observed 
fixed effects.  The results of this modelling clearly showed a statistically significant pathway from 
cannabis to psychotic symptoms (B = .352, SE = .087, p < .001); but a statistically non-significant and 
weaker pathway from psychotic symptoms to cannabis use (B = -.045, SE = .043, p > .25).  The results 
of this analysis showed that the apparent causal linkages between cannabis use and psychotic 
symptoms in the CHDS database could not be accounted for by reverse causal processes in which 
psychotic symptoms increased the risk of cannabis use.  Estimates of the attributable risk suggest 
that cannabis use accounted for approximately 12% of the rate of psychotic symptoms amongst the 
cohort.   
 
While the mechanisms linking cannabis use to increased risks of psychotic symptomatology are not 
entirely clear, it is likely that the linkage involves the activation of the dopamine and serotonin 
systems in the brain [71].  Both of these neurotransmitters are known to be involved in the 
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maintenance of psychotic mental states [72].  In addition, there has been some evidence to suggest 
that the associations between cannabis use and psychotic symptomatology may be influenced by 
gene x environment interactions.  Caspi and colleagues found evidence that carriers of the COMT 
valine158 allele were at greater risk of psychotic symptomatology after using cannabis [73].  
However, these findings have not been replicated by other studies [74-77], and further studies have 
examined other possible gene by environment interactions in the linkages between cannabis use 
and psychotic symptomatology [78-80].  It is clear that further research on possible gene x 
environment interactions is needed not only to elucidate the linkages between cannabis and 
psychosis, but also to explore the role of genetic factors in linkages between cannabis and other 
psychosocial outcomes. 
 
Additional findings on cannabis from the CHDS 
In addition to the findings described above, data from the CHDS has been used in a number of other 
investigations to examine the sequelae of cannabis use for a range of psychosocial and other 
outcomes.  Some of these additional findings include: 
a) Cannabis and major depression: Examination of the CHDS data [81], and a meta-analysis of 
data from several longitudinal cohorts including the CHDS [82] suggest that there is a 
modest association between cannabis use and increased risk of major depression.  It is 
unclear, however, to what extent these findings may be explained by reverse causal 
processes in which depression increases the risk of cannabis use; 
b) Cannabis and suicidal ideation:  A recent investigation [83] suggests that, amongst males in 
the CHDS cohort, earlier and heavier use of cannabis strongly increases the risk of suicidal 
thoughts.  These findings are consistent with earlier studies using CHDS data examining 
suicidal ideation and suicide attempt [81]; 
c) Cannabis and tobacco use:  An additional recent examination of CHDS data [70] showed 
evidence of a reciprocal causal association between cannabis use and tobacco use, such that 
increasing levels of cannabis use increased the risk of tobacco use, and vice-versa.  This 
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evidence is consistent with both “gateway” and “reverse gateway” [84] explanations of the 
association between cannabis use and tobacco use. 
d) Cannabis and risk of motor vehicle accidents:  An examination of CHDS data at age 25 [85] 
found evidence that, after adjustment for confounding, self-reported driving under the 
influence of cannabis was associated with a marginally (p < .10) increased risk of motor 
vehicle accidents in which the cohort member (driver) was at fault.  By way of contrast, the 
linkage between self-reported driving under the influence of alcohol and motor vehicle 
accidents was not statistically significant (p > .70) after adjustment for confounding. 
e) Cannabis use in adolescence and criminal offending:  CHDS data were also used to analyze 
the linkages between the frequency of cannabis use during mid-adolescence (ages 15-16) 
and several measures of criminal offending, including self-reported violent and property 
offending, arrest and conviction [26].  The analyses showed an association between the 
frequency of cannabis use and each of the offending measures, after controlling for social 
disadvantage, family adversity, early onset behavioural problems, and affiliation with 
deviant peers. 
 
The consequences of cannabis use for regular adult users 
Most cannabis research has focused on documenting the harms of cannabis use.  A topic that has 
not been addressed concerns the proportion of adult users who use cannabis in a non-problematic 
way.  It is likely that this group of users, quite reasonably, provides the major critical commentary on 
the adverse effects of the prohibition of cannabis [5].   
 
To examine this issue, for the purposes of the present investigation, CHDS data were used to classify 
cohort members according to their frequency of cannabis use during the period 30-35 years, ranging 
from “no cannabis use” to “at least weekly cannabis use”.  For each level of cannabis use frequency, 
the risk of having at least one of several psychosocial problems described previously (major 
depression; suicidal ideation; psychotic symptomatology; welfare dependence; being unemployed 
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for at least six months) during the period 30-35 years was computed.  The results these analyses are 
presented in Figure 5, which shows the percentage of individuals for each level of cannabis use 
frequency that reported at least one psychosocial problem.  The Figure shows that the risk of 
psychosocial problems amongst cannabis users ranged from 41.9% (occasional users) to 49.3% (at 
least weekly use), as compared with 27.5% for non-users. It should be noted that these comparisons 
do not address the psychosocial issues likely faced by long-term chronic users of cannabis [86-89]; 
however, these comparisons do highlight the fact that while regular users of cannabis have elevated 
rates of problems, by no means do all users experience these difficulties.   
 
INSERT FIGURE 5 HERE 
 
Cannabis and public policy 
An ongoing debate in the area of cannabis has focused upon: a) the extent to which cannabis has 
harmful consequences; and b) the legal and societal response to these problems [3,1].  These 
debates have led to a polarization of views with pro-cannabis advocates arguing that cannabis has 
minimal harms [5-7], and that any harmful effects can be attributed to prohibition and its adverse 
consequences.  Alternatively, there has been a growing body of empirical evidence clearly 
suggesting that cannabis has adverse effects in a number of areas of psychosocial functioning, 
including reduced educational achievement; increased risk of welfare dependence and 
unemployment; increased risk of the use of other illicit drugs; and increased risk of psychotic 
symptomatology [1,3,4,90]. 
 
At the same time, as we have shown above, by no means all cannabis users, or even heavy users, 
suffer adverse consequences of cannabis use.  In turn, these findings lead to consideration of the 
most appropriate social and legal methods for regulating a moderate risk drug which is widely used.  
There are a variety of responses to this issue, ranging from strict prohibition to recent US policy 
changes whereby cannabis has been either fully legalized, or legalized for medical purposes [90].  
16 
 
Which of these models provides the best approach to addressing issues relating to cannabis remains 
a matter of debate.  It is our view that the best approach to addressing this issue is through a 
systematic quasi-experimental approach, in which legislation relating to the supply and consumption 
of cannabis is progressively liberalized, with these innovations being assessed to determine their 
positive and negative consequences.  Regrettably, this approach has not been widely adopted, with 
the result that changes in cannabis policy have often been large and seldom adequately evaluated.  
A possible exception to this was the experiment conducted in Portugal, where not only cannabis but 
all illicit drugs were decriminalized in 2001.  Several years later, a study evaluating the effect of the 
law change found that there had been no increase in drug use amongst the population, and in fact 
the prevalence of drug use in the 15-19 year age group had declined for all drugs including cannabis 
[91,92].  While the interpretation of the evidence following the law change in Portugal has been 
subject to some controversy [93], it is clear that any legal or policy changes in regard to cannabis 
must be subject to rigorous evaluation. 
 
Summary and Conclusions 
In summary, it is our conclusion that the accumulated findings of the CHDS suggest that cannabis 
use, and in particular heavy use and use at younger ages, is associated with increased risks in a 
number of areas of functioning, including: a) educational achievement; b) welfare dependence; c) 
unemployment; d) other illicit drug use; and e) psychotic symptomatology.  These findings have 
contributed to a growing body of evidence that suggests that cannabis is a drug that does confer 
some degree of risk [4,90].  However, it is also clear that not all cannabis users experience the 
problems associated with cannabis.  The reviewed findings highlight the importance of developing 
well-evaluated policies to minimize the harmful consequences of cannabis use, whilst at the same 
time protecting the rights of the large number of users who experience no harmful consequences. 
 
While most of the CHDS findings point to the adverse effects of cannabis use and particularly heavy 
use on a number of outcomes (e.g. educational achievement; welfare dependence; unemployment; 
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other illicit drug use; psychotic symptomatology) this evidence remains contentious. Specifically pro-
cannabis groups [5-7] and others [2,94] have consistently argued that the apparent associations 
between cannabis and adverse outcomes is due to faulty research design and particularly failure to 
control  confounding factors. These comments are reminiscent of the claims of the tobacco industry 
in its defense of cigarette smoking. The position taken is, in effect, that since research cannot 
eliminate all possibility that the relationships between cannabis and adverse outcomes are 
confounded by non-observed factors and processes, any evidence suggesting harmful effects of 
cannabis can be discounted and ignored. It is our view that this logic is deeply flawed. In particular, 
in situations in which research produces consistent evidence that a given practice may have harmful 
consequences, the precautionary principle [95,96] requires that these findings should be taken 
seriously and not discounted on the basis of non-observed processes and findings. This approach 
does not imply that an uncritical attitude should be taken to evidence of cannabis and adverse 
consequences, but it does require that this evidence should not be rejected on the basis of claims, 
conjectures and hypotheses that have not been subject to empirical test.  As the history of research 
into the adverse consequences of tobacco smoking shows [97], what is required  is an accumulation 
of evidence from different sources and different methods that supports a common conclusion. 
Looked at from this perspective, the findings of the CHDS can be seen as part of a growing body of 
evidence documenting the adverse consequences of heavy cannabis use. 
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Figure 1 Panel a: Cannabis use, regular (at least weekly) cannabis use, and cannabis dependence at 
each assessment (ages 15-35) 
 
Figure 1 Panel b: Cumulative rates of cannabis use, regular (at least weekly) cannabis use, and 











Figure 2 Panel a: Adjusted rates of educational attainment (to age 30) by age of onset of cannabis 
use 
 
Figure 2 Panel b: Adjusted OR for welfare dependence (ages 21-25) amongst those using cannabis 
(ages 15-21), compared to non-users 
 
Figure 2 Panel c: Adjusted OR for unemployment (ages 21-25) amongst those using cannabis (ages 








Figure 3 Panel a: %reporting other illicit drug use by frequency of cannabis use, at selected ages 
 
Figure 3 Panel b: Adjusted OR for other illicit drug use, by frequency of cannabis use (pooled over 14-








Figure 4: Adjusted IRR for rate of symptoms of psychosis by frequency of cannabis use (pooled over 






Figure 5: % reporting at least one psychosocial problem, by frequency of cannabis use (ages 30-35) 
 
